277 related articles for article (PubMed ID: 2431540)
21. Characteristics and location of cross-reactive and serotype-specific neutralization sites on VP7 of human G type 9 rotaviruses.
Kirkwood C; Masendycz PJ; Coulson BS
Virology; 1993 Sep; 196(1):79-88. PubMed ID: 8395127
[TBL] [Abstract][Full Text] [Related]
22. Characterization of neutralization epitopes on the VP7 surface protein of serotype G11 porcine rotaviruses.
Ciarlet M; Hidalgo M; Gorziglia M; Liprandi F
J Gen Virol; 1994 Aug; 75 ( Pt 8)():1867-73. PubMed ID: 7519247
[TBL] [Abstract][Full Text] [Related]
23. Identification of a new neutralization epitope on VP7 of human serotype 2 rotavirus and evidence for electropherotype differences caused by single nucleotide substitutions.
Dunn SJ; Ward RL; McNeal MM; Cross TL; Greenberg HB
Virology; 1993 Nov; 197(1):397-404. PubMed ID: 7692670
[TBL] [Abstract][Full Text] [Related]
24. The outer capsid glycoprotein VP7 of simian rotavirus SA11 contains two distinct neutralization epitopes.
Gerna G; Sarasini A; di Matteo A; Passarani N; Gagliardi V; Milanesi G; Astaldi Ricotti GC; Battaglia M
J Gen Virol; 1988 Apr; 69 ( Pt 4)():937-44. PubMed ID: 2451709
[TBL] [Abstract][Full Text] [Related]
25. Comparisons of rotavirus VP7-typing monoclonal antibodies by competition binding assay.
Raj P; Matson DO; Coulson BS; Bishop RF; Taniguchi K; Urasawa S; Greenberg HB; Estes MK
J Clin Microbiol; 1992 Mar; 30(3):704-11. PubMed ID: 1372622
[TBL] [Abstract][Full Text] [Related]
26. Passive protection against rotavirus-induced diarrhea by monoclonal antibodies to the heterotypic neutralization domain of VP7 and the VP8 fragment of VP4.
Matsui SM; Offit PA; Vo PT; Mackow ER; Benfield DA; Shaw RD; Padilla-Noriega L; Greenberg HB
J Clin Microbiol; 1989 Apr; 27(4):780-2. PubMed ID: 2470774
[TBL] [Abstract][Full Text] [Related]
27. Derivation of neutralizing monoclonal antibodies to human rotaviruses and evidence that an immunodominant neutralization site is shared between serotypes 1 and 3.
Coulson BS; Tursi JM; McAdam WJ; Bishop RF
Virology; 1986 Oct; 154(2):302-12. PubMed ID: 2429439
[TBL] [Abstract][Full Text] [Related]
28. Preparation and characterization of neutralizing monoclonal antibodies with different reactivity patterns to human rotaviruses.
Taniguchi K; Urasawa S; Urasawa T
J Gen Virol; 1985 May; 66 ( Pt 5)():1045-53. PubMed ID: 2987395
[TBL] [Abstract][Full Text] [Related]
29. Neutralizing monoclonal antibodies against three serotypes of porcine rotavirus.
Nagesha HS; Brown LE; Holmes IH
J Virol; 1989 Aug; 63(8):3545-9. PubMed ID: 2545925
[TBL] [Abstract][Full Text] [Related]
30. Identification of the two rotavirus genes determining neutralization specificities.
Offit PA; Blavat G
J Virol; 1986 Jan; 57(1):376-8. PubMed ID: 3001359
[TBL] [Abstract][Full Text] [Related]
31. Monoclonal antibodies to Quebec strain (Q17) of bovine rotavirus.
Cornaglia E; Elazhary Y; Roy RS; Talbot B
Vet Microbiol; 1990 Jun; 23(1-4):283-94. PubMed ID: 1698323
[TBL] [Abstract][Full Text] [Related]
32. Cross-reactive, serotype- and monotype-specific neutralization epitopes on VP7 of serotype G3 and G5 porcine rotavirus strains.
Ciarlet M; Hidalgo M; Liprandi F
Arch Virol; 1996; 141(3-4):601-14. PubMed ID: 8645098
[TBL] [Abstract][Full Text] [Related]
33. Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates.
Coulson BS; Fowler KJ; Bishop RF; Cotton RG
J Virol; 1985 Apr; 54(1):14-20. PubMed ID: 2579249
[TBL] [Abstract][Full Text] [Related]
34. Analysis by plaque reduction neutralization assay of intertypic rotaviruses suggests that gene reassortment occurs in vivo.
Hoshino Y; Sereno MM; Midthun K; Flores J; Chanock RM; Kapikian AZ
J Clin Microbiol; 1987 Feb; 25(2):290-4. PubMed ID: 2434522
[TBL] [Abstract][Full Text] [Related]
35. Serotypic analysis of VP3 and VP7 neutralization escape mutants of rhesus rotavirus.
Shaw RD; Mackow ER; Dyall-Smith ML; Lazdins I; Holmes IH; Greenberg HB
J Virol; 1988 Sep; 62(9):3509-12. PubMed ID: 2457117
[TBL] [Abstract][Full Text] [Related]
36. Antibodies to rotavirus outer capsid glycoprotein VP7 neutralize infectivity by inhibiting virion decapsidation.
Ludert JE; Ruiz MC; Hidalgo C; Liprandi F
J Virol; 2002 Jul; 76(13):6643-51. PubMed ID: 12050377
[TBL] [Abstract][Full Text] [Related]
37. Antibodies to the trypsin cleavage peptide VP8 neutralize rotavirus by inhibiting binding of virions to target cells in culture.
Ruggeri FM; Greenberg HB
J Virol; 1991 May; 65(5):2211-9. PubMed ID: 1850007
[TBL] [Abstract][Full Text] [Related]
38. Localization of rotavirus VP4 neutralization epitopes involved in antibody-induced conformational changes of virus structure.
Zhou YJ; Burns JW; Morita Y; Tanaka T; Estes MK
J Virol; 1994 Jun; 68(6):3955-64. PubMed ID: 7514681
[TBL] [Abstract][Full Text] [Related]
39. Monoclonal antibodies to bovine coronavirus: characteristics and topographical mapping of neutralizing epitopes on the E2 and E3 glycoproteins.
Deregt D; Babiuk LA
Virology; 1987 Dec; 161(2):410-20. PubMed ID: 2446421
[TBL] [Abstract][Full Text] [Related]
40. Neutralization of rotavirus and recognition of immunologically important epitopes on VP4 and VP7 by human IgA.
Johansen K; Svensson L
Arch Virol; 1997; 142(7):1491-8. PubMed ID: 9267458
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
